Skip to main content
Clinical Trials/JPRN-UMIN000031144
JPRN-UMIN000031144
Completed
未知

Study to verify the effect of sleep quality improvement effect and nighttime blood glucose level change by using 4-layer special three-dimensional mattress - Study to verify the effect of sleep quality improvement effect and nighttime blood glucose level change by using 4-layer special three-dimensional mattress

Anti-Aging Bank Co.,Ltd.0 sites12 target enrollmentFebruary 9, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy volunteer
Sponsor
Anti-Aging Bank Co.,Ltd.
Enrollment
12
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 9, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Anti-Aging Bank Co.,Ltd.

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • \[1]Individuals using medical products \[2]Individuals under treatment or with history of mental disorders, sleep disorders, hypertension, diabetes, lipid metabolism abnormality, or other serious disorders \[3]Individuals who are suspected, recived treatment of, or have a history of sleep apnea syndrome \[4]Individuals who have or are suspected with the night urination, prostatomegaly, or overactive bladder \[5]Individuals receiving/received medical drug treatment for the past 1 month except for temporary relief medication for headache, menstrual pain, common cold, etc. \[6]Individuals with history of serious diseases (hepatic, renal, cardiovascular, respiratory, hematologic, etc.) \[7]Individuals with history of gastrointestinal disorders except for appendicitis \[8]Individuals with \>\=25\.0kg/m2 BMI \[9]Individuals who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months \[10]Individuals who have experienced mood disorder or condition deterioration due to blood sampling in the past \[11]Individuals deemed sensitive to the test product or highly allergic to foods or medical drugs \[12]Individuals who have the possibility of developing seasonal allergic symptoms such as hay fever and the possibility of using medicines (eyedrops, nose drops are acceptable) \[13]Individuals who continuously ingest supplements that have effects on blood glucose levels and supplements that contain vitamin C and those who intend to consume during the study period (but not those who can stop taking the intake at the time of consent acquisition) \[14]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) \[15]Individuals whose life style will change during the test period (ex. travel for a long time) \[16]Individuals who are or are posslibly, or are lactating \[17]Individuals with a scheduled or likely to visit an MRI examination during the period of this study etc.

Outcomes

Primary Outcomes

Not specified

Similar Trials